
|Articles|November 17, 2003
First drug approved for severe Alzheimer's
Clinicians will soon be able to treat patients with advanced Alzheimer?s disease (AD) using the first drug approved for use in the later stages of this progressive condition. The FDA recently approved memantine (Namenda, Forest Laboratories) for the treatment of moderate to severe AD. The drug will be available in pharmacies January.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths
2
TrumpRx Promising Direct-to-Consumer Drugs for Discounted Prices
3
PCVs Significantly Reduce Pneumococcal Meningitis in Children
4
The Regimen: Pharmacists Bridging the Treatment Gap for Patients with OUD
5





































































































































